Invitation to Roche’s Virtual Event on the SBX (sequencing by expansion) technology Montag, 10. Februar 2025 - 10:20

Investor Update

Invitation to Roche's Virtual Event on the SBX (sequencing by expansion) technology

We are pleased to invite investors and analysts to participate in our virtual event on Thursday, 20 February 2025, providing an update on Roche's sequencing by expansion (SBX) technology.

20:30 – 21:30 CET / 19:30 – 20:30 GMT
2:30 – 3:30 pm EST / 11:30 – 12:30 pm PST

The webinar will start with a presentation, followed by a Q&A session (live access to the speakers). The slides will be available for download at 19:30 CET on the day of the event.
> click here

Speakers:

Matt Sause, CEO Roche Diagnostics
Palani Kumaresan, Head of Roche Diagnostics Solutions (RDS)
Josh Lauer, Head of Molecular Labs Customer Area

Access to virtual event (pre-registration required)
Please pre-register for our webinar here*.

Should you be unable to register for the webinar due to your company IT policy, please send an e-mail to investor.relations@roche.com.

A replay of the webcast will be available via > ir.roche.com

*privacy notice

Best regards,

Bruno Eschli Head of Investor Relations	Birgit Masjost Investor Relations Officer

Roche Investor Relations
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com	Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com

Investor Relations North America
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com